Welcome to our dedicated page for IBIC news (Ticker: IBIC), a resource for investors and traders seeking the latest updates and insights on IBIC stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect IBIC's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of IBIC's position in the market.
BlackRock (NYSE:BLK) announced the planned termination of the iShares iBonds Oct 2026 Term TIPS ETF (NYSE Arca: IBIC). The ETF’s last trading day and final NAV calculation are scheduled for October 15, 2026, with an expected liquidation date of October 20, 2026.
According to BlackRock, iBonds ETFs are designed to mature in a specific year, then transition from bonds into short-term instruments and cash before liquidation. Shareholders are expected to receive liquidation proceeds on or around the liquidation date, depending on their brokerage’s processes. Other iShares iBonds ETFs remain available across treasuries, municipals, investment grade and high yield corporates.